Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Meirong Zang
Low Serum miR-19a Expression as a Novel Poor Prognostic Indicator in Multiple Myeloma
International Journal of Cancer
Cancer Research
Oncology
Related publications
Prognostic Value of CD56 Expression in Multiple Myeloma
Research in Oncology
TAZ Expression as a Prognostic Indicator in Colorectal Cancer
PLoS ONE
Multidisciplinary
Serum miR-26a as a Diagnostic and Prognostic Biomarker in Cholangiocarcinoma
Oncotarget
Oncology
Low Expression of Aldo–keto Reductase 1B10 Is a Novel Independent Prognostic Indicator for Nasopharyngeal Carcinoma
Cell and Bioscience
Biochemistry
Genetics
Molecular Biology
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and in Vivo Evidence
Clinical Cancer Research
Cancer Research
Oncology
Serum Bone Sialoprotein as a Marker of Tumour Burden and Neoplastic Bone Involvement and as a Prognostic Factor in Multiple Myeloma
British Journal of Cancer
Cancer Research
Oncology
Evaluation of Serum Β 2-Microglobulin as a Prognostic Indicator in Myelomatosis
British Journal of Cancer
Cancer Research
Oncology
High Expression of UBE2T Predicts Poor Prognosis and Survival in Multiple Myeloma
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
MicroRNA-19a Acts as a Prognostic Marker and Promotes Prostate Cancer Progression via Inhibiting VPS37A Expression
Oncotarget
Oncology